UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis

PloS one, 2019-07, Vol.14 (7), p.e0217263-e0217263

2019

Volltextzugriff (PDF)

Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial

PloS one, 2018-09, Vol.13 (9), p.e0203054-e0203054

2018

Volltextzugriff (PDF)

NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet (British edition), 2018-03, Vol.391 (10126), p.1174-1185

2018

Volltextzugriff (PDF)

Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort

Journal of hepatology, 2021-08, Vol.75 (2), p.284-291

2021

Volltextzugriff (PDF)

Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver Disease

대한소화기학회지, 2021, 78(3), , pp.161-167

2021

Volltextzugriff (PDF)

Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis

Gastroenterology (New York, N.Y. 1943), 2021-01, Vol.160 (1), p.219-231.e1

2021

Volltextzugriff (PDF)

Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis

Journal of hepatology, 2019-04, Vol.70 (4), p.735-744

2019

Volltextzugriff (PDF)

The Great Masquerader: Syphilis Presenting as Rectal Ulcer in the Setting of Neurosyphilis: 1617

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S930-S930

2018

Volltextzugriff (PDF)

Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome: 2236

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S1269-S1270

2018

Volltextzugriff (PDF)

Drug-induced liver injury in 2007

Current opinion in gastroenterology, 2008-05, Vol.24 (3), p.287-297

2008

Volltextzugriff (PDF)

One-hour Recovery Time in Subjects Undergoing Percutaneous Liver Biopsy: A Quality Improvement and Patient Safety Project

Curēus (Palo Alto, CA), 2019-09

2019

Volltextzugriff (PDF)

Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection

The Annals of pharmacotherapy, 2007-05, Vol.41 (5), p.880-884

2007

Volltextzugriff (PDF)

Su1045 Utility of Evaluating HCV in an Uninsured Population: Is the Bang Worth the Buck?

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-973-S-973

2014

Volltextzugriff (PDF)

664 – Hepatocellular Carcinoma Screening Rates in a Free Access Medical System: How Can We Do Better? (Poster Presentation)

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-141-S-141

2019

Volltextzugriff (PDF)

698 - Hepatitis A and B Vaccination Rates Among Liver Biopsy Confirmed NAFL or NASH in a Free Access Medical System: How can we do Better?

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-142-S-142

2018

Volltextzugriff (PDF)

Endoscopic Recognition of Giant Colonic Diverticula: 1822

The American journal of gastroenterology, 2017-10, Vol.112, p.S999-S1000

2017

Volltextzugriff (PDF)

Treatment of nonalcoholic fatty liver disease: Role of dietary modification and exercise

Clinical liver disease (Malden, Mass.), 2012-09, Vol.1 (4), p.117-118

2012

Volltextzugriff (PDF)

Mo1461 – Outcomes in Nonalcoholic Fatty Liver Disease Associated Hepatocellular Carinoma Treated with Transarterial Radioembolization with Yttrium-90

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-1314-S-1315

2019

Volltextzugriff (PDF)

Hepatitis A and B Vaccination Rates Among Liver Biopsy Confirmed Nonalcoholic Fatty Liver or Nonalcoholic Steatohepatitis in a Free Access Medical System: How Can We Do Better?

Gastroenterology (New York, N.Y. 1943), 2018-07, Vol.155 (1), p.e42-e43

2018

Volltextzugriff (PDF)

Su1520 - The Prevalence of Small Intestinal Bacterial Overgrowth in Adults with Non-Alcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-1166-S-1166

2018

Volltextzugriff (PDF)

Su1535 - The Relationship Between Non-Alcoholic Fatty Liver Disease and Periodontal Disease

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-1170-S-1170

2018

Volltextzugriff (PDF)

A Rare Case of Periampullary Tumor: 2424

The American journal of gastroenterology, 2017-10, Vol.112, p.S1321

2017

Volltextzugriff (PDF)

A Case of Grade 3 Hepatotoxicity due to Dasatinib: 2257

The American journal of gastroenterology, 2017-10, Vol.112, p.S1241-S1242

2017

Volltextzugriff (PDF)

Esophageal Neuroendocrine Carcinoma Presenting as a Rare Cause of Dysphagia: 1675

The American journal of gastroenterology, 2017-10, Vol.112, p.S908

2017

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(46)

Sprache

Englisch
(45)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis

Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial

NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort

Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver Disease

Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis

Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis

The Great Masquerader: Syphilis Presenting as Rectal Ulcer in the Setting of Neurosyphilis: 1617

Thymoma-Induced Autoimmune Hepatitis: A Rare Paraneoplastic Syndrome: 2236

Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases

Drug-induced liver injury in 2007

One-hour Recovery Time in Subjects Undergoing Percutaneous Liver Biopsy: A Quality Improvement and Patient Safety Project

Terbinafine-induced acute autoimmune hepatitis in the setting of hepatitis B virus infection

Su1045 Utility of Evaluating HCV in an Uninsured Population: Is the Bang Worth the Buck?

664 – Hepatocellular Carcinoma Screening Rates in a Free Access Medical System: How Can We Do Better? (Poster Presentation)

698 - Hepatitis A and B Vaccination Rates Among Liver Biopsy Confirmed NAFL or NASH in a Free Access Medical System: How can we do Better?

Endoscopic Recognition of Giant Colonic Diverticula: 1822

Treatment of nonalcoholic fatty liver disease: Role of dietary modification and exercise

Mo1461 – Outcomes in Nonalcoholic Fatty Liver Disease Associated Hepatocellular Carinoma Treated with Transarterial Radioembolization with Yttrium-90

Hepatitis A and B Vaccination Rates Among Liver Biopsy Confirmed Nonalcoholic Fatty Liver or Nonalcoholic Steatohepatitis in a Free Access Medical System: How Can We Do Better?

Su1520 - The Prevalence of Small Intestinal Bacterial Overgrowth in Adults with Non-Alcoholic Fatty Liver Disease

Su1535 - The Relationship Between Non-Alcoholic Fatty Liver Disease and Periodontal Disease

A Rare Case of Periampullary Tumor: 2424

A Case of Grade 3 Hepatotoxicity due to Dasatinib: 2257

Esophageal Neuroendocrine Carcinoma Presenting as a Rare Cause of Dysphagia: 1675

Suchergebnisse filtern